Ransdell Pierson

Exclusive: Germany OKs Northwest Bio brain cancer drug, shares soar

November 4, 2021 at 1:22 a.m.

(Reuters) - Germany has granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug in the country, the company said, and its stock jumped as much as...

Exclusive: Germany OKs Northwest Bio brain cancer drug, shares soar

May 14, 2019 at 5:42 a.m.

(Reuters) - Germany has granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug in the country, the company said, and its stock jumped as much as...

Pfizer’s Prevnar prevents pneumonia in elderly – study

May 14, 2019 at 5:38 a.m.

(Reuters) - Pfizer Inc said on Monday that Prevnar 13, its blockbuster vaccine against childhood infections, prevented pneumonia outside of hospitals in people age 65 and older, in one of...

Death of actor Philip Seymour Hoffman spotlights fentanyl scourge

August 25, 2021 at 1:01 a.m.

(Reuters) - Investigators are racing to find the source of a synthetic narcotic called fentanyl that is sometimes mixed with heroin and is believed by health authorities to be responsible...

J&J cautious view on 2014 profit, drug sales, hits shares

August 25, 2021 at 12:29 a.m.

(Reuters) - Healthcare company Johnson & Johnson cautioned Tuesday that prescription-drug sales would likely lose some momentum this year and forecast 2014 earnings at the lower end of Wall Street...

Sanofi to buy 12 percent of Alnylam, expands rare-disease drug deal

August 25, 2021 at 12:18 a.m.

SAN FRANCISCO (Reuters) - French drugmaker Sanofi will buy a 12 percent stake in Alnylam Pharmaceuticals Inc for $700 million and deepen their partnership to develop drugs for rare genetic...

Sanofi to buy 12 percent of Alnylam, expands rare-disease drug deal

May 14, 2019 at 5:31 a.m.

SAN FRANCISCO (Reuters) - French drugmaker Sanofi will buy a 12 percent stake in Alnylam Pharmaceuticals Inc for $700 million and deepen their partnership to develop drugs for rare genetic...

Stellar hepatitis C data puts Gilead farther ahead of pack

May 14, 2019 at 5:26 a.m.

(Reuters) - Gilead Sciences Inc released impressive late-stage data Wednesday for its once-daily combination pill to treat hepatitis C, advancing its lead in the race to develop new, all-oral treatments...

FDA panel backs Bristol, Astra diabetes drug after prior rejection

August 24, 2021 at 11:11 p.m.

(Reuters) - By a lopsided vote of 13 to 1, an independent committee of medical experts voted on Thursday to recommend approval of a new type of diabetes drug that...

FDA panel backs Bristol, Astra diabetes drug after prior rejection

May 14, 2019 at 5:25 a.m.

(Reuters) - By a lopsided vote of 13 to 1, an independent committee of medical experts voted on Thursday to recommend approval of a new type of diabetes drug that...

All Stories